Ovarian Cysts Clinical Trial
Official title:
Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients
Clear cell carcinoma comprises 5-10% of surface epithelial ovarian cancers, and about 30-40% of the patients with clear cell carcinoma are diagnosed in the advanced stage. The investigators studied the response to chemotherapy and survival for either paclitaxel-platinum based chemotherapy or conventional platinum-based chemotherapy among all stages clear cell ovarian carcinoma. Prognostic factors for survival among the patients with pure, advanced, clear cell ovarian carcinoma were also evaluated.
1. Several authors have reported frequent admixtures of clear cell ovarian carcinoma with
serous, mucinous, and endometrioid tumors. However, few papers addressed the difference
in response to chemotherapy and survival between patients with pure and mixed-type
advanced clear cell carcinoma.
2. Recent trends in the clinical management of advanced ovarian cancer include increased
attention to maximal cytoreduction and general acceptance of paclitaxel-platinum-based
adjuvant chemotherapy.
3. The introduction of paclitaxel markedly changed the postoperative management of ovarian
cancer patients, but the results and value of these newer efforts and therapies applied
to clear cell carcinoma are as yet undetermined.
4. Today, paclitaxel-platinum-based chemotherapy is becoming the standard regimen for
ovarian cancer worldwide. Previous research suggests a potential benefit of paclitaxel
plus carboplatin regimens for stage I clear cell carcinoma. However, few papers
specifically addressed the efficacy of paclitaxel-platinum-based chemotherapy for
advanced clear cell carcinoma because clear cell carcinoma occurs only rarely in Western
countries.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02890914 -
Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents
|
N/A | |
| Completed |
NCT01779232 -
Danazol Treatment in Endometriosis Women Before IVF
|
Phase 4 | |
| Completed |
NCT05054946 -
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
|
N/A | |
| Completed |
NCT02852447 -
The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve
|
N/A | |
| Completed |
NCT00713778 -
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst
|
Phase 4 | |
| Suspended |
NCT00865488 -
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
|
Phase 3 | |
| Completed |
NCT04142203 -
Implementation of 23 Hour Surgery Model in a Tertiary Hospital
|
||
| Recruiting |
NCT05842629 -
Improved Diagnosis of Ovarian Cancer
|
||
| Completed |
NCT05376384 -
Ovarian Cyst's Enucleation Spillage Score
|
||
| Recruiting |
NCT04993924 -
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
|
Phase 4 | |
| Terminated |
NCT03189316 -
Anti-inflammatory Cells in Peritoneal Cavity
|
N/A | |
| Completed |
NCT05800613 -
Management of Ovarian Masses in Pediatric Patients: an Italian Survey
|
||
| Completed |
NCT04355312 -
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy
|
N/A | |
| Completed |
NCT05418595 -
Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
|
||
| Completed |
NCT06342934 -
Radiomics and Machine Learning in the Diagnosis of Ovarian Masses
|
||
| Completed |
NCT06227676 -
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
|
Phase 2/Phase 3 | |
| Completed |
NCT02831556 -
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
|
||
| Recruiting |
NCT05763511 -
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
|
||
| Completed |
NCT06064331 -
Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements
|
N/A | |
| Recruiting |
NCT02086318 -
A New Algorithm to Predict Ovarian Age
|
N/A |